TY - JOUR
T1 - Specific CD8 T cells in IgE-mediated allergy correlate with allergen dose and allergic phenotype
AU - Aguilar-Pimentel, Juan A.
AU - Alessandrini, Francesca
AU - Huster, Katharina M.
AU - Jakob, Thilo
AU - Schulz, Holger
AU - Behrendt, Heidrun
AU - Ring, Johannes
AU - De Angelis, Martin Hrabé
AU - Busch, Dirk H.
AU - Mempel, Martin
AU - Ollert, Markus
PY - 2010/1/1
Y1 - 2010/1/1
N2 - Rationale: Studies in humans and rodents have indicated a causative role for CD8 + T cells in IgE-mediated allergic inflammation, but their function is still controversial. Objectives: Toanalyze the role of allergen-specific CD8 + T cells during the development of allergic airway inflammation in two parallel but diverging outcome models. Methods: We used H2-Kb SIINFEKL (OVA 257-264) multimers to analyze induction, natural distribution, and phenotype of allergen-specific CD8 + T cells in amurine C57BL/6 model of ovalbumin (OVA)-induced allergic airway inflammation using low-dose or high-dose OVA sensitization. Measurements and Main Results: The low-dose protocol was characterized by a significant induction of total and OVA-specific IgE, eosinophilic airway inflammation, IL-4 levels in bronchoalveolar lavage fluid. And significant alterations in lung function. The high dose protocol was characterizedbya significant reductionof theallergicphenotype. Using OVA 257-264 H2-Kb multimers, we observed lung and airway infiltrating OVA-specific CD8 + T cells showing an effector/effectormemory phenotype. The high-dose protocol caused significantly higher infiltration of allergen-specific CD8 + cells to the airways and enhanced their cytotoxicity. Adoptive transferwith CD8 + T cells from transgenic OT-I mice to TAP1 -/- or wild-type mice showed their migration to the lungs and TAP1-dependent proliferation after OVA aerosol exposure. TAP1 -/- mice defective in CD8 + T cells showed exacerbated symptoms in the low-dose sensitizationmodel. Conclusions: Allergen-specific CD8 + T cells seem to protect from allergic inflammation in the lungs. Their number, which is dependent on the sensitization dose, appears to be a critical predictor for the severity of the allergic phenotype.
AB - Rationale: Studies in humans and rodents have indicated a causative role for CD8 + T cells in IgE-mediated allergic inflammation, but their function is still controversial. Objectives: Toanalyze the role of allergen-specific CD8 + T cells during the development of allergic airway inflammation in two parallel but diverging outcome models. Methods: We used H2-Kb SIINFEKL (OVA 257-264) multimers to analyze induction, natural distribution, and phenotype of allergen-specific CD8 + T cells in amurine C57BL/6 model of ovalbumin (OVA)-induced allergic airway inflammation using low-dose or high-dose OVA sensitization. Measurements and Main Results: The low-dose protocol was characterized by a significant induction of total and OVA-specific IgE, eosinophilic airway inflammation, IL-4 levels in bronchoalveolar lavage fluid. And significant alterations in lung function. The high dose protocol was characterizedbya significant reductionof theallergicphenotype. Using OVA 257-264 H2-Kb multimers, we observed lung and airway infiltrating OVA-specific CD8 + T cells showing an effector/effectormemory phenotype. The high-dose protocol caused significantly higher infiltration of allergen-specific CD8 + cells to the airways and enhanced their cytotoxicity. Adoptive transferwith CD8 + T cells from transgenic OT-I mice to TAP1 -/- or wild-type mice showed their migration to the lungs and TAP1-dependent proliferation after OVA aerosol exposure. TAP1 -/- mice defective in CD8 + T cells showed exacerbated symptoms in the low-dose sensitizationmodel. Conclusions: Allergen-specific CD8 + T cells seem to protect from allergic inflammation in the lungs. Their number, which is dependent on the sensitization dose, appears to be a critical predictor for the severity of the allergic phenotype.
KW - Airway inflammation
KW - Asthma
KW - Cytotoxicity
KW - Immunotherapy
KW - Tolerance
UR - http://www.scopus.com/inward/record.url?scp=73849149166&partnerID=8YFLogxK
U2 - 10.1164/rccm.200902-0190OC
DO - 10.1164/rccm.200902-0190OC
M3 - Article
C2 - 19815810
AN - SCOPUS:73849149166
SN - 1073-449X
VL - 181
SP - 7
EP - 16
JO - American Journal of Respiratory and Critical Care Medicine
JF - American Journal of Respiratory and Critical Care Medicine
IS - 1
ER -